140 related articles for article (PubMed ID: 28884883)
1. Diagnostic imaging using positron emission tomography for gynecological malignancy.
Tsuyoshi H; Yoshida Y
J Obstet Gynaecol Res; 2017 Nov; 43(11):1687-1699. PubMed ID: 28884883
[TBL] [Abstract][Full Text] [Related]
2. Detection of extra-regional tumour recurrence with
Brar H; May T; Tau N; Langer D; MacCrostie P; Han K; Metser U
Clin Radiol; 2017 Apr; 72(4):302-306. PubMed ID: 28108013
[TBL] [Abstract][Full Text] [Related]
3. Current Update on PET/MRI in Gynecological Malignancies-A Review of the Literature.
Virarkar M; Vulasala SS; Calimano-Ramirez L; Singh A; Lall C; Bhosale P
Curr Oncol; 2023 Jan; 30(1):1077-1105. PubMed ID: 36661732
[TBL] [Abstract][Full Text] [Related]
4. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer.
Khiewvan B; Torigian DA; Emamzadehfard S; Paydary K; Salavati A; Houshmand S; Shamchi SP; Werner TJ; Aydin A; Roy SG; Alavi A; Kumar R
Hell J Nucl Med; 2016; 19(3):254-268. PubMed ID: 27824966
[TBL] [Abstract][Full Text] [Related]
5. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
6. Pitfalls in [¹⁸F]FDG PET imaging in gynecological malignancies.
Hernandez Pampaloni M; Facchetti L; Nardo L
Q J Nucl Med Mol Imaging; 2016 Jun; 60(2):124-38. PubMed ID: 26937887
[TBL] [Abstract][Full Text] [Related]
7. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
8. The Role of Positron Emission Tomography/Magnetic Resonance Imaging in Gynecological Malignancies.
Virarkar M; Viswanathan C; Iyer R; de Castro Faria S; Morani A; Carter B; Ganeshan D; Elsherif S; Bhosale PR
J Comput Assist Tomogr; 2019; 43(6):825-834. PubMed ID: 31453978
[TBL] [Abstract][Full Text] [Related]
9. Present and future role of FDG-PET/CT imaging in the management of breast cancer.
Kitajima K; Miyoshi Y
Jpn J Radiol; 2016 Mar; 34(3):167-80. PubMed ID: 26733340
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies.
Grisaru D; Almog B; Levine C; Metser U; Fishman A; Lerman H; Lessing JB; Even-Sapir E
Gynecol Oncol; 2004 Sep; 94(3):680-4. PubMed ID: 15350358
[TBL] [Abstract][Full Text] [Related]
12. Gynecological cancers.
Avril N; Gourtsoyianni S; Reznek R
Methods Mol Biol; 2011; 727():171-89. PubMed ID: 21331934
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of
Jung JH; Lee SW; Son SH; Kim CY; Lee CH; Jeong JH; Jeong SY; Ahn BC; Lee J
Head Neck; 2017 Mar; 39(3):447-455. PubMed ID: 27726225
[TBL] [Abstract][Full Text] [Related]
14. What's New in Imaging for Gynecologic Cancer?
Khan SR; Arshad M; Wallitt K; Stewart V; Bharwani N; Barwick TD
Curr Oncol Rep; 2017 Nov; 19(12):85. PubMed ID: 29105030
[TBL] [Abstract][Full Text] [Related]
15. [¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective.
Mangili G; Bergamini A; Giorgione V; Picchio M; Petrone M; Mapelli P; Rabaiotti E; Incerti E; Candiani M
Q J Nucl Med Mol Imaging; 2016 Jun; 60(2):103-16. PubMed ID: 26868372
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography-computed tomography imaging for malignancies in women.
Viswanathan C; Bhosale PR; Shah SN; Vikram R
Radiol Clin North Am; 2013 Nov; 51(6):1111-25. PubMed ID: 24210447
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
19. How We Read Oncologic FDG PET/CT.
Hofman MS; Hicks RJ
Cancer Imaging; 2016 Oct; 16(1):35. PubMed ID: 27756360
[No Abstract] [Full Text] [Related]
20. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
